THC
18–22%
CBD
0.2%
A well-rounded hybrid that blends relaxation with mild uplifting effects, perfect for evening wind-down.
Explore More
Terpene Fingerprint
Relative terpene levels from lab and source data
THC in this profile
22% THC
About Blue Trilogy
Blue Trilogy is a hybrid strain that offers a mix of relaxed, sleepy, and uplifted effects with 22% THC, ideal for easing inflammation and pain while providing a comforting body high. Myrcene and caryophyllene as the leading terpenes deliver berry and earthy flavors that make it taste as good as it feels, with a smooth finish that promotes deep rest. What sets this one apart is its versatile hybrid profile, blending calming indica vibes with a touch of sativa uplift, perfect for transitioning from a busy day to peaceful evenings.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Blue Trilogy
Is Blue Trilogy an Indica, Sativa, or Hybrid?
Blue Trilogy is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Blue Trilogy?
Blue Trilogy: 22% THC and 0.2% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.
What are the common effects of Blue Trilogy?
Our data sources report these effects for Blue Trilogy: relaxed, uplifted, sleepy. Individual experiences vary.
What does Blue Trilogy taste and smell like?
Our data sources list flavors of berry, earthy and terpenes such as Caryophyllene, Myrcene for Blue Trilogy.
If You Like Blue Trilogy, Try...
Shared reported terpene or flavor notes; effects may differ
